General Information of DTT (ID: TTD7Q0R)

DTT Name Cytochrome P450 26 (CYP26A1) DTT Info
UniProt ID
CP26A_HUMAN
Gene Name CYP26A1

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Clinical Trial Drug(s)
Investigative Drug(s)
2 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
LIAROZOLE DM4OYXE Dermatological disease DA24.Y Phase 2/3 [1]
Rambazole DMP2DNS Psoriasis vulgaris EA90 Phase 2 [2]
------------------------------------------------------------------------------------
2 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
4-((+/-)-(1H-imidazol-1-yl)-(E)-methylretinoate DMI15VQ Discovery agent N.A. Investigative [3]
4-((+/-)-(1H-imidazol-1-yl)-(E)-retinoic acid DMKYB4D Discovery agent N.A. Investigative [3]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Novel azolyl-(phenylmethyl)]aryl/heteroarylamines: potent CYP26 inhibitors and enhancers of all-trans retinoic acid activity in neuroblastoma cells. Bioorg Med Chem. 2008 Sep 1;16(17):8301-13.
2 Emerging drugs for psoriasis. Expert Opin Emerg Drugs. 2009 Mar;14(1):145-63.
3 Novel retinoic acid metabolism blocking agents endowed with multiple biological activities are efficient growth inhibitors of human breast and pros... J Med Chem. 2004 Dec 30;47(27):6716-29.